Page 1 of Clinical Trials for rifampicin, 196 Total Matches
- 1CompletedLast Updated: June 9, 2011Condition(s): Tuberculosis
- 2RecruitingLast Updated: July 12, 2011Condition(s): Pulmonary Tuberculosis (TB)
- 3CompletedLast Updated: March 24, 2011Condition(s): Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4; Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4; Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19 Inhibitor.
- 4CompletedEffects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects.Last Updated: July 21, 2011Condition(s): Rheumatoid Arthritis; Healthy Volunteers
- 5Active, not recruitingLast Updated: July 27, 2010Condition(s): Alzheimer's Disease
- 6CompletedLast Updated: June 11, 2008Condition(s): Coronary Artery Disease
- 7RecruitingLast Updated: April 13, 2011Condition(s): Tuberculosis
- 8Active, not recruitingLast Updated: December 3, 2010Condition(s): HIV Infections; Tuberculosis
- 9CompletedLast Updated: April 12, 2012Condition(s): Infection Due to Resistant Bacteria; Pneumonia, Ventilator-Associated; Hospital Acquired Pneumonia; Infection of Bloodstream; Infectious Disease of Abdomen
- 10CompletedLast Updated: November 18, 2009Condition(s): Healthy
- 11Active, not recruitingLast Updated: February 6, 2012Condition(s): Multiple System Atrophy
- 12CompletedLast Updated: July 28, 2011Condition(s): Pharmacokinetics of Darexaban and Metabolites; Healthy Subjects
- 13RecruitingLast Updated: December 29, 2011Condition(s): Drug Safety
- 14RecruitingLast Updated: May 21, 2012Condition(s): Infection
- 15CompletedLast Updated: January 24, 2011Condition(s): Alzheimer Disease
- 16CompletedLast Updated: December 3, 2010Condition(s): HIV Infections; Tuberculosis
- 17Active, not recruitingLast Updated: March 7, 2012Condition(s): Solid Tumors
- 18CompletedLast Updated: June 4, 2010Condition(s): HIV Infections; Tuberculosis
- 19CompletedLast Updated: March 3, 2009Condition(s): Pharmacokinetics of YM178
- 20RecruitingLast Updated: June 18, 2009Condition(s): HIV Infection; Tuberculosis
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=rifampicin
